Blackford Platform is purpose-built for seamless integration with current systems. It
simplifies
management of multiple AI applications and algorithms, reduces system load, and ensures 24/7
performance monitoring via Blackford Dashboard™.
Our Strategic Partnerships include providers of medical imaging platforms, clinical workflow
solutions, pharma, cloud services and medical imaging equipment.
Neurovascular imaging AI tool launches on Blackford Platform
Blackford first platform to offer CINA Head from Avicenna.AI to support emergency room triage for intracranial hemorrhages and large vessel occlusions. Edi
Blackford Analysis
Blackford first platform to offer CINA Head from Avicenna.AI to support emergency room triage for intracranial hemorrhages and large vessel occlusions.
Edinburgh, UK & Paris, FRANCE – September 29, 2020 –Blackford, the centralized medical imaging platform, today announced that it is the first platform provider to offer the
CINA Head triage AI solution for neurovascular emergencies from Avicenna.AI. Blackford customers can now benefit from the tool’s automatic detection capabilities for both intracranial hemorrhage (ICH) and large vessel occlusion (LVO) from CT-scan imaging. Using a combination of deep learning and machine learning technologies, CINA Head is FDA-approved and automatically detects and prioritizes acute ICH and LVO cases within 20 seconds, seamlessly alerting the radiologist within their existing systems and workflow. “Stroke is a leading cause of death and more than a third of strokes happen either because of LVO or ICH,” said
Ben Panter, CEO, Blackford Analysis. “We are excited to be the first platform to offer CINA Head and look forward to providing healthcare facilities with a tool that can identify these pathologies quickly and then highlights the cases that require the most urgent care.” Fully integrated with existing systems, Blackford Platform simplifies the deployment and management of multiple imaging applications and AI algorithms. New applications can easily be added to the image-processing platform, reducing implementation time, costs, and long-term maintenance. “Blackford has built a great reputation based on the curation of the best applications on the market, so we are delighted that CINA Head is now available on this platform,” said
Cyril Di Grandi, co-founder and CEO, Avicenna.AI. “We are eager to start working with emergency departments and stroke centers to help improve detection, decision-making and patient outcomes.”
About Avicenna.AI Founded in 2018, Avicenna.AI develops medical imaging AI solutions for pathologies with a high occurrence. The company uses artificial intelligence and deep learning to optimize many of a radiologist’s manual tasks. Avicenna.AI is co-founded by Cyril Di Grandi, founder of Olea Medical, which was acquired by Canon Medical Systems, and Dr Peter Chang, a radiologist and internationally recognized expert in AI and deep learning.
www.avicenna.aiAbout Blackford Blackford provides a single platform to quickly access and manage a curated marketplace of regulatory approved medical image analysis applications and AI algorithms that add clinical value. Easily integrated into existing workflows, the platform provides actionable information that allows healthcare providers to use imaging information smartly and reduce the cost of care, while improving diagnostic confidence and patient outcomes. Founded in 2010, and with operations in the United Kingdom and the United States, Blackford Analysis is backed by TRI Cap, Old College Capital, and Archangel Investors, one of the UK’s leading business angel syndicates.
www.blackfordanalysis.com
